Home » Topics » BioWorld Science

BioWorld Science
RSS

New antifungals from Lilly

Jan. 2, 1998

Alcon discloses new antiglaucoma agents in patent literature

Jan. 2, 1998

Akzo Nobel describes new gonadotropins with therapeutic potential

Jan. 2, 1998

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

Cambridge Antibody Technology: FY 1997 highlights

Dec. 31, 1997

FDA deems Provigil approvable

Dec. 31, 1997

Favorable phase III trial results reported for HER2 monoclonal antibody

Dec. 31, 1997

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...